These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 32495876
1. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma. Qiu ML, Li X, Lin JB, Luo RG, Liu B, Feng Z. Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876 [Abstract] [Full Text] [Related]
2. Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma. Gao LR, Zhang J, Huang N, Deng W, Ni W, Xiao Z, Liu M. Int J Mol Sci; 2024 May 31; 25(11):. PubMed ID: 38892269 [Abstract] [Full Text] [Related]
3. Plasma-derived Exosomal miR-25-3p and miR-23b-3p as Predictors of Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma. Jing Z, Guo Z, Zhang C. Technol Cancer Res Treat; 2024 May 31; 23():15330338241289520. PubMed ID: 39380461 [Abstract] [Full Text] [Related]
5. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H. Cancer; 2013 Mar 15; 119(6):1159-67. PubMed ID: 23224754 [Abstract] [Full Text] [Related]
9. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma. Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y. Tumour Biol; 2016 Apr 15; 37(4):4383-91. PubMed ID: 26499784 [Abstract] [Full Text] [Related]
18. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer. Zhang W, Su X, Li S, Liu Z, Wang Q, Zeng H. Cancer Biomark; 2020 Apr 15; 27(4):485-491. PubMed ID: 32065786 [Abstract] [Full Text] [Related]